{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:52:15Z","timestamp":1792763535029,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.humpath.2022.06.001","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T03:40:23Z","timestamp":1654918823000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8370-6508","authenticated-orcid":false,"given":"Yoh","family":"Zen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.06.001_bib1","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/modpathol.2017.22","article-title":"Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas","volume":"30","author":"Akita","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib2","series-title":"Intrahepatic cholangiocarcinoma. World Health Organization classification of digestive system tumours","first-page":"254","author":"Nakanuma","year":"2019"},{"key":"10.1016\/j.humpath.2022.06.001_bib3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0b013e31802b34b6","article-title":"Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type","volume":"31","author":"Aishima","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","article-title":"Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma","volume":"40","author":"Hayashi","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib6","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/PAS.0000000000001118","article-title":"Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns","volume":"42","author":"Sigel","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1365-2559.2011.04048.x","article-title":"Two distinct pathways of carcinogenesis in primary sclerosing cholangitis","volume":"59","author":"Zen","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.06.001_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humpath.2020.12.005","article-title":"An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping","volume":"109","author":"Akita","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib9","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0000000000000957","article-title":"C-reactive protein (CRP) is a promising diagnostic immunohistochemical marker for intrahepatic cholangiocarcinoma and is associated with better prognosis","volume":"41","author":"Yeh","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1245\/s10434-014-4247-8","article-title":"The ability to diagnose intrahepatic cholangiocarcinoma definitively using novel branched DNA-enhanced albumin RNA in situ hybridization technology","volume":"23","author":"Ferrone","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2022.06.001_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/PAS.0000000000001006","article-title":"MDM2 amplification in intrahepatic cholangiocarcinomas: its relationship with large-duct type morphology and uncommon KRAS mutations","volume":"42","author":"Kim","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jhbp.988","article-title":"Prediction of mismatch repair deficient biliary tract cancer: role of morphological features and host immune response detected by routine hematoxylin-eosin staining","volume":"28","author":"Suda","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.humpath.2022.06.001_bib13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ajcp\/aqz199","article-title":"Mismatch repair protein deficiency\/microsatellite instability is rare in cholangiocarcinomas and associated with distinctive morphologies","volume":"153","author":"Ju","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1200\/JCO.2020.38.4_suppl.574","article-title":"NTRK gene fusions in biliary tract cancers","volume":"38S","author":"Demols","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.06.001_bib15","first-page":"404A","article-title":"Tubulocystic carcinoma of bile ducts: a hitherto unrecognized and diagnostically challenging entity often mistaken as a benign lesion; clinicopathologic analysis of 6 cases","volume":"26","author":"Jang","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001886","article-title":"Thymic mucoepidermoid carcinoma: a clinicopathologic and molecular study","author":"Murase","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41523-020-0164-0","article-title":"Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes","volume":"6","author":"Pareja","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.humpath.2022.06.001_bib18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ng1083","article-title":"t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway","volume":"33","author":"Tonon","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2022.06.001_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.humpath.2020.02.001","article-title":"Pathologic grading of mucoepidermoid carcinomas of the salivary gland and its effect on clinicopathologic follow-up: an institutional experience","volume":"98","author":"Shafique","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib20","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1158\/1078-0432.CCR-05-2376","article-title":"MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma","volume":"12","author":"Okabe","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.06.001_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1872-034X.2008.00335.x","article-title":"Mucoepidermoid carcinoma of the liver: report of a rare case and review of the literature","volume":"38","author":"Arakawa","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1016\/j.humpath.2022.06.001_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1746-1596-9-24","article-title":"Unusual mucoepidermoid carcinoma of the liver misdiagnosed as squamous cell carcinoma by intraoperative histological examination","volume":"9","author":"Guo","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13000-021-01086-3","article-title":"Whole-exome sequencing reveals the etiology of the rare primary hepatic mucoepidermoid carcinoma","volume":"16","author":"Hou","year":"2021","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13000-019-0863-8","article-title":"Primary mucoepidermoid carcinoma of the liver with CRTC1-MAML2 fusion: a case report","volume":"14","author":"Watanabe","year":"2019","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.15403\/jgld.2014.1121.262.gus","article-title":"Esophageal adenocarcinoma with enteroblastic differentiation arising in ectopic gastric mucosa in the cervical esophagus: a case report and literature review","volume":"26","author":"Gushima","year":"2017","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.humpath.2022.06.001_bib26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2147\/CMAR.S288913","article-title":"Extra-Hepatic hepatoid carcinomas in female reproductive system: three case-reports with a literature review","volume":"13","author":"Liu","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.humpath.2022.06.001_bib27","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1159\/000511763","article-title":"Alpha-fetoprotein-producing lung hepatoid adenocarcinoma with brain metastasis treated with S-1","volume":"13","author":"Muroyama","year":"2020","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.humpath.2022.06.001_bib28","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s12328-020-01209-1","article-title":"Colonic clear cell adenocarcinoma with enteroblastic differentiation","volume":"13","author":"Shiratori","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.001_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.humpath.2021.02.003","article-title":"Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers","volume":"115","author":"He","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/pin.13226","article-title":"Hepatoid carcinoma and related entities of the extrahepatic bile duct: a clinicopathological study of four cases","author":"Okura","year":"2022","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2022.06.001_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humpath.2020.12.002","article-title":"Mimics of hepatocellular carcinoma: a review and an approach to avoiding histopathological diagnostic missteps","volume":"112","author":"Arif","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/PAS.0b013e3181d1dcdd","article-title":"SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma","volume":"34","author":"Ushiku","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib33","doi-asserted-by":"crossref","first-page":"799163","DOI":"10.3389\/fmed.2021.799163","article-title":"\u03b1-Fetoprotein-Producing endometrial carcinoma is associated with fetal gut-like and\/or hepatoid morphology, lymphovascular infiltration, TP53 abnormalities, and poor prognosis: five cases and literature review","volume":"8","author":"Otani","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.humpath.2022.06.001_bib34","doi-asserted-by":"crossref","first-page":"633916","DOI":"10.3389\/fonc.2021.633916","article-title":"Hepatoid adenocarcinoma of the stomach: current perspectives and new developments","volume":"11","author":"Xia","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2022.06.001_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.humpath.2021.09.006","article-title":"Genomic characterization of hepatoid tumors: context matters","volume":"118","author":"Lawlor","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib36","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1097\/PAS.0000000000001729","article-title":"A novel NIPBL-NACC1 gene fusion is characteristic of the cholangioblastic variant of intrahepatic cholangiocarcinoma","volume":"45","author":"Argani","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.humpath.2017.02.001","article-title":"Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as \"cholangioblastic variant of intrahepatic cholangiocarcinoma","volume":"62","author":"Braxton","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib38","doi-asserted-by":"crossref","first-page":"e00746","DOI":"10.14309\/crj.0000000000000746","article-title":"A cholangioblastic variant of cholangiocarcinoma","volume":"9","author":"Verhoeff","year":"2022","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.humpath.2022.06.001_bib39","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00428-005-1241-3","article-title":"Hepatic adenocarcinoma expressing inhibin in a young patient on oral contraceptives","volume":"446","author":"Vrettou","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.06.001_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.humpath.2021.07.004","article-title":"Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma","volume":"116","author":"Wen","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00000478-199302000-00010","article-title":"Biliary adenofibroma. A heretofore unrecognized benign biliary tumor of the liver","volume":"17","author":"Tsui","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/PAS.0000000000000773","article-title":"Biliary adenofibroma of liver: morphology, tumor genetics, and outcomes in 6 cases","volume":"41","author":"Arnason","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib43","first-page":"8068513","article-title":"Biliary adenofibroma with invasive carcinoma: case report and review of the literature","volume":"2016","author":"Godambe","year":"2016","journal-title":"Case Rep Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s40792-019-0661-2","article-title":"A case of biliary adenofibroma of the liver with malignant transformation: a morphomolecular case report and review of the literature","volume":"5","author":"Sturm","year":"2019","journal-title":"Surg Case Rep"},{"key":"10.1016\/j.humpath.2022.06.001_bib45","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.prp.2015.12.015","article-title":"A case of biliary adenofibroma with malignant transformation","volume":"212","author":"Thai","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2022.06.001_bib46","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2214\/ajr.179.1.1790280","article-title":"Biliary adenofibroma with malignant transformation and pulmonary metastases: CT findings","volume":"179","author":"Akin","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.humpath.2022.06.001_bib47","series-title":"World Health Organization classification of digestive system tumours","first-page":"279","article-title":"Intraductal papillary neoplasm of the bile ducts","author":"Nakanuma","year":"2019"},{"key":"10.1016\/j.humpath.2022.06.001_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.humpath.2020.12.010","article-title":"Cystic biliary tumors of the liver: diagnostic criteria and common pitfalls","volume":"112","author":"Shyu","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib49","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/his.13037","article-title":"Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas","volume":"69","author":"Fujikura","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.06.001_bib50","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1097\/PAS.0000000000001155","article-title":"Recurrent mutations in APC and CTNNB1 and activated wnt\/beta-catenin signaling in intraductal papillary neoplasms of the bile duct: a whole exome sequencing study","volume":"42","author":"Fujikura","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib51","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/PAS.0000000000001237","article-title":"Intracholecystic papillary neoplasms are distinct from papillary gallbladder cancers: a clinicopathologic and exome-sequencing study","volume":"43","author":"Akita","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.001_bib52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.surg.2013.08.011","article-title":"Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion: a single-institution study with 184 patients","volume":"155","author":"Onoe","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2022.06.001_bib53","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1007\/s00330-018-5841-0","article-title":"CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas","volume":"29","author":"Komori","year":"2019","journal-title":"Eur Radiol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:42:05Z","timestamp":1758645725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722001460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":53,"alternative-id":["S0046817722001460"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.06.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}